(VIR) – Analyst Comments
-
BofA Securities Downgrades Vir Biotechnology (VIR) to Neutral, 'Near-term data unlikely to lift sentiment'
-
Vir Biotechnology (VIR) upgraded on 'attractive upside potential' from positive data
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VIR Stock Lookup